Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 60.74 -0.74 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.48 | 52 Week High | $8.22 | |||
| Open | $60.54 | 52 Week Low | $3.07 | |||
| Day High | $61.13 | P/E | N/A | |||
| Day Low | $59.21 | EPS | $-1.30 | |||
| Volume | 1,784,718 | |||||
